These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19250128)

  • 1. The use of QALYs in clinical and patient decision-making: issues and prospects.
    Kind P; Lafata JE; Matuszewski K; Raisch D
    Value Health; 2009 Mar; 12 Suppl 1():S27-30. PubMed ID: 19250128
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: On the benefits of modeling using QALYs for societal resource allocation: the model is the message.
    Garrison LP
    Value Health; 2009 Mar; 12 Suppl 1():S36-7. PubMed ID: 19250130
    [No Abstract]   [Full Text] [Related]  

  • 3. QALYs: some challenges.
    Nord E; Daniels N; Kamlet M
    Value Health; 2009 Mar; 12 Suppl 1():S10-5. PubMed ID: 19250125
    [No Abstract]   [Full Text] [Related]  

  • 4. QALYs: the basics.
    Weinstein MC; Torrance G; McGuire A
    Value Health; 2009 Mar; 12 Suppl 1():S5-9. PubMed ID: 19250132
    [No Abstract]   [Full Text] [Related]  

  • 5. Toward a consensus on the QALY.
    Drummond M; Brixner D; Gold M; Kind P; McGuire A; Nord E;
    Value Health; 2009 Mar; 12 Suppl 1():S31-5. PubMed ID: 19250129
    [No Abstract]   [Full Text] [Related]  

  • 6. Determing the threshold of acceptability of an ICER when natural health units are used.
    Hyewon HL; Levine M
    J Popul Ther Clin Pharmacol; 2012; 19(2):e234-8. PubMed ID: 22805014
    [No Abstract]   [Full Text] [Related]  

  • 7. QALY-time: experts' view on the use of the quality-adjusted LIFE year in COST-effectiveness analysis in palliative care.
    Wichmann AB; Goltstein LCMJ; Obihara NJ; Berendsen MR; Van Houdenhoven M; Morrison RS; Johnston BM; Engels Y;
    BMC Health Serv Res; 2020 Jul; 20(1):659. PubMed ID: 32678021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-adjusted life-years. Ethical implications for physicians and policymakers.
    La Puma J; Lawlor EF
    JAMA; 1990 Jun; 263(21):2917-21. PubMed ID: 2110986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elicitation of informed general population health state utility values: a review of the literature.
    McTaggart-Cowan H
    Value Health; 2011 Dec; 14(8):1153-7. PubMed ID: 22152187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multi-Fidelity Rollout Algorithm for Dynamic Resource Allocation in Population Disease Management.
    Ho TY; Liu S; Zabinsky ZB
    Health Care Manag Sci; 2019 Dec; 22(4):727-755. PubMed ID: 30194509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision QALYs, Precisely Unjust.
    Fleck LM
    Camb Q Healthc Ethics; 2019 Jul; 28(3):439-449. PubMed ID: 31298190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness versus cost-utility analysis of interventions for cancer: does adjusting for health-related quality of life really matter?
    Tengs TO
    Value Health; 2004; 7(1):70-8. PubMed ID: 14720132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB).
    Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G
    Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing principles, QALYs, and the straw men of resource allocation.
    McMillan J; Hope T
    Am J Bioeth; 2010 Apr; 10(4):48-50. PubMed ID: 20379922
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of health economics in clinical decision-making: is it ethical?
    Williams A
    Respir Med; 1991 Sep; 85 Suppl B():3-5. PubMed ID: 1759019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an alternative to quality-adjusted life years for supporting healthcare decision making?
    Beresniak A; Dupont D
    Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):351-7. PubMed ID: 27139424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life: the contested rhetoric of resource allocation and end-of-life decision making.
    Nantais D; Kuczewski M
    J Med Philos; 2004 Dec; 29(6):651-64. PubMed ID: 15590514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of life and utility measures: clinical parameters for decision-making in health].
    Campolina AG; Ciconelli RM
    Rev Panam Salud Publica; 2006 Feb; 19(2):128-36. PubMed ID: 16551387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Intervention Impact on Health Inequality for Resource Allocation.
    Griffin S; Love-Koh J; Pennington B; Owen L
    Med Decis Making; 2019 Apr; 39(3):171-182. PubMed ID: 30819034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
    Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
    Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.